ClinicalTrials.govpublic full text
A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma
multiple myeloma, myeloma, plasma cell myeloma, bone marrow cancer, myelomatosis, kahler's disease, pxd101, belinostat, bortezomib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 978915
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.